Relationship Between Morbimortality and Basal Activated Clotting Time (ACT) in Patients Undergoing Vascular Surgery

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau30 enrolled

Overview

Check whether patients with higher comorbidity and risk of complication, estimated using the V (p) -POSSUM score, ACS NSQIP and the ASA classification, present higher baseline activated clotting time values.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Artery Disease, Peripheral Aortic Diseases Carotid Artery Diseases Other Disease

Interventions

Activated clotting timeDIAGNOSTIC_TEST

Relationship between elongated baseline activated clotting time and comorbidity

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients undergoing vascular surgery requiring intraoperative heparinization Exclusion Criteria: * Pregnant women * SARS-CoV-2 PCR positive (performed 24-72h prior to surgery) * Severe plaquetopenia \<50,000

Outcomes

Primary Outcomes

Change on baseline Activated Clotting Time with comorbidities

Activted Clotting Time will be measured with Haemocron Machine just before surgery. Comorbidities will be measured with V(p)Possum, AC NSQUIP and ASA scales.

Time frame: 1 day - surgery day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.